Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain

Contraception - Tập 80 - Trang 457-462 - 2009
Lorenzo Arribas-Mir1,2,3, Dolores Rueda-Lozano1,3, María Agrela-Cardona1,3, Tania Cedeño-Benavides1,3, Carmen Olvera-Porcel4, Aurora Bueno-Cavanillas2,5,4
1University Health Centre of La Chana, Health District of Granada, Andalusian Health Service, Granada 18015, Spain
2Department of Preventive Medicine and Public Health, University of Granada, Granada 18014, Spain
3Teaching Unit of Family and Community Medicine of Granada, Andalusian Health Service, Granada 18001, Spain
4CIBER Epidemiology and Public Health (CIBERESP), Granada 18014, Spain
5Preventive Medicine Service, University Hospital San Cecilio, Andalusian Health Service, Granada 18014, Spain

Tài liệu tham khảo

Voluntary interruption of pregnancy Trussell, 2007, Contraceptive efficacy, 747 Le, 2001, Implanon: a critical review, Ann Pharmacother, 35, 329, 10.1345/aph.10149 Jordan, 2002, Toxicology of progestogens of implantable contraceptives for women, Contraception, 65, 3, 10.1016/S0010-7824(01)00283-9 Edwards, 1999, Implanon. A review of clinical studies, Br J Fam Plann, 24, 3 Mattos, 2004, Satisfaction, efficacy, side effects of the subdermal implant Implanon® In two advice centers for women of the Community of Madrid, Rev Iberoam Fertil, 21, 93 Davie, 1996, Impact of patient counselling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom, Clin Ther, 18, 150, 10.1016/S0149-2918(96)80187-1 World Health Organization, 2004, Reproductive health and research. Improving access to quality care in family planning Belsey, 1986, The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction, Contraception, 34, 253, 10.1016/0010-7824(86)90006-5 World Health Organization, 2005 Otero, 2005, Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant, Int J Gynaecol Obstet, 90, 228, 10.1016/j.ijgo.2005.06.007 Rai, 2004, Experience with Implanon in a northeast London family planning clinic, Eur J Contracept Reprod Health Care, 9, 39, 10.1080/13625180410001696223 Agrawal, 2005, An assessment of the first 3 years' use of Implanon in Luton, J Fam Plann Reprod Health Care, 31, 310, 10.1783/147118905774480581 Lakha, 2006, Continuation rates of Implanon in the UK: data from an observational study in a clinical setting, Contraception, 74, 287, 10.1016/j.contraception.2006.05.072 Murat, 2008, Effect of the subdermal contraceptive etonogestrel implant (Implanon) on biochemical and hormonal parameters (three years follow-up), Eur J Contracept Reprod Health Care, 13, 238, 10.1080/13625180802075315 Vieira, 2007, Use of etonogestrel-releasing implant is associated with hypoactivation of coagulation cascade, Hum Reprod, 22, 2196, 10.1093/humrep/dem153 Belsey, 1988, The analysis of menstrual bleeding patterns: a review, Contraception, 38, 129, 10.1016/0010-7824(88)90035-2 Ginegranada Clinic. (Internet Page). Granada. (Quantitative and comparative study in relation to abortion and other aspects of reproductive health of immigrant women). Spa. Inc.; c2004–2007 (updated 2008 Dec 14; cited 2009 Jan 25). Available at: http://www.ginegranada.com. V Questionnaire Bayer Schering Pharma. Contraception in Spain 2007. (Internet Page). Spa. Daphne Group. (Update 2007; cited 2009 Abril 6). Available at: http://www.equipodaphne.es/encuestas.php. Zheng, 1999, A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant, Contraception, 60, 1, 10.1016/S0010-7824(99)00053-0 National Institute for Health and Clinical Excellence. (Internet Page). London. Long-acting reversible contraception. Economic evaluation; p 113–136. Inc.; c2007 (updated 2007 Oct 26; cited 2009 24 Jan). Available at: http://www.nice.org.uk/nicemedia/pdf/CG030fullguideline.pdf. Kiriwat, 1998, A 4-year pilot study on the efficacy and safety of Implanon, a single-rod hormonal contraceptive implant, in healthy women in Thailand, Eur J Contracept Reprod Health Care, 3, 85, 10.3109/13625189809051409 Affandi, 1999, A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for ≤4 years, Contraception, 59, 167, 10.1016/S0010-7824(99)00015-3 Croxatto, 1999, A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group, Hum Reprod, 14, 976, 10.1093/humrep/14.4.976 Zheng, 1999, A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China, Eur J Contracept Reprod Health Care, 4, 85, 10.3109/13625189909064009 Affandi, 1998, An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon, Contraception, 58, 99S, 10.1016/S0010-7824(98)00123-1 Darney, 2008, Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials, Fertil Steril, 18 Aubeny, 2006, Will period-free hormonal contraception become the norm of the twenty-first century?, Eur J Contracept Reprod Health Care, 11, 1, 10.1080/13625180500389711 Harrison-Woolrycha, 2005, Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia, Contraception, 71, 306, 10.1016/j.contraception.2004.10.005 Webb, 2006, Why go to Tiger Country? A report of two cases of Implanon removal, J Fam Plann Reprod Health Care, 32, 193, 10.1783/147118906777888233 Wechselberger, 2006, Nerve injury caused by removal of an implantable hormonal contraceptive, Am J Obstet Gynecol, 195, 323, 10.1016/j.ajog.2005.09.016